Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multifocal ERG Findings After Intravitreal Bevacizumab
NCT00417833Phase 3Terminated
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Dec 2005
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of bevacizumab in proliferative diabetic retinopathy (PDR), retinal vein occlusion (RVO), choroidal neovascularization (CNV), sponsored by Asociación para Evitar la Ceguera en México. Started Dec 2005; status: terminated.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)retinal vein occlusion (RVO)choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT00417833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417833.